Tecovirimat Well Tolerated Among Patients With Monkeypox, But Effectiveness Remains Unclear, Researchers Say

MedPage Today (9/12, Hein) reports, “Tecovirimat (Tpoxx) was well tolerated among patients with monkeypox virus infection, though its efficacy in monkeypox is currently unclear, CDC researchers said.” The findings of the research that included “patients t...